跳至主要内容
临床试验/NL-OMON24865
NL-OMON24865招募中不适用

A randomized placebo controlled double blind clinical trial comparing selenium and pentoxifylline in patients with mild Graves' orbitopathy.

Prof. dr. W.M. WiersingaDept. of Endocrinology and MetabolismAcademic Medical CenterMeibergdreef 91105 AZ AmsterdamT: +31 20 5666071F: +31 20 6917682e-mail: w.m.wiersinga@amc.uva.nl0 个研究点目标入组 156 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
156

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Graves' hyperthyroidism, euthyroid for at least two months by antithyroid drugs of surgery (at least 6 months if I131 is used;
  • 2. Mild Graves' ophthalmopathy (at least 1 sign), with a disease duration of less than 18 months;
  • 3. No past treatment of the ophthalmopathy except for local measures;
  • 4. Age 18-70 years.

排除标准

  • 1. NOSPECS class 2c;
  • 2. Proptosis >22 mm;
  • 3. Diplopia in primary or reading position, and/or ocular torticollis;
  • 4. Mono-ocular duction in any direction of less than 20 degrees;
  • 5. Optic nerve involvement;
  • 6. Pregnancy, drugs/alcohol abuse, severe concomitant illness, no informed consent, use of selenium or pentoxifylline containing preparations.

研究者

发起方
Prof. dr. W.M. WiersingaDept. of Endocrinology and MetabolismAcademic Medical CenterMeibergdreef 91105 AZ AmsterdamT: +31 20 5666071F: +31 20 6917682e-mail: w.m.wiersinga@amc.uva.nl

相似试验